Truist Financial Sticks to Their Buy Rating for Cytokinetics (CYTK)

TipRanks5minutes ago · Ratings

Why Cytokinetics Stock Was a Nearly 5% Winner Today

Yahoo FinanceDec 21 06:25

H.C. Wainwright Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $120

Futu NewsDec 21 03:31 · Ratings

Cytokinetics Price Target Maintained With a $120.00/Share by HC Wainwright & Co.

Dow JonesDec 20 23:29 · Ratings

Cytokinetics Says Sanofi Acquiring Rights for Aficamten in Greater China

MT NewswiresDec 20 16:58

Express News | Cytokinetics Inc - Eligible for up to $150 Million in Milestone Payments From Sanofi

BreakingsDec 20 13:00